Literature DB >> 22832793

Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex.

Gislaine T Rezin1, Giselli Scaini, Gabriela K Ferreira, Mariane R Cardoso, Cinara L Gonçalves, Larissa S Constantino, Pedro F Deroza, Fernando V Ghedim, Samira S Valvassori, Wilson R Resende, João Quevedo, Alexandra I Zugno, Emilio L Streck.   

Abstract

Fenproporex is an amphetamine-based anorectic and it is rapidly converted in vivo into amphetamine. It elevates the levels of extracellular dopamine in the brain. Acetylcholinesterase is a regulatory enzyme which is involved in cholinergic synapses and may indirectly modulate the release of dopamine. Thus, we investigated whether the effects of chronic administration of fenproporex in adult rats alters acquisition and retention of avoidance memory and acetylcholinesterase activity. Adult male Wistar rats received repeated (14 days) intraperitoneal injection of vehicle or fenproporex (6.25, 12.5 or 25 mg/kg i.p.). For behavioral assessment, animals were submitted to inhibitory avoidance (IA) tasks and continuous multiple trials step-down inhibitory avoidance (CMIA). Acetylcholinesterase activity was measured in the prefrontal cortex, hippocampus, hypothalamus and striatum. The administration of fenproporex (6.25, 12.5 and 25 mg/kg) did not induce impairment in short and long-term IA or CMIA retention memory in rats. In addition, longer periods of exposure to fenproporex administration decreased acetylcholinesterase activity in prefrontal cortex and striatum of rats, but no alteration was verified in the hippocampus and hypothalamus. In conclusion, the present study showed that chronic fenproporex administration decreased acetylcholinesterase activity in the rat brain. However, longer periods of exposure to fenproporex did not produce impairment in short and long-term IA or CMIA retention memory in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22832793     DOI: 10.1007/s11011-012-9331-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  48 in total

1.  Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay.

Authors:  T Kraemer; G A Theis; A A Weber; H H Maurer
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-01-28

Review 2.  Section I. The cholinergic system.

Authors:  John Smythies
Journal:  Int Rev Neurobiol       Date:  2005       Impact factor: 3.230

3.  Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes.

Authors:  G Page; M Peeters; M Najimi; J M Maloteaux; E Hermans
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

Review 4.  Structural roles of acetylcholinesterase variants in biology and pathology.

Authors:  D Grisaru; M Sternfeld; A Eldor; D Glick; H Soreq
Journal:  Eur J Biochem       Date:  1999-09

Review 5.  Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology.

Authors:  Israel Silman; Joel L Sussman
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

6.  Comparative cholinergic neurotoxicity of oral chlorpyrifos exposures in preweanling and adult rats.

Authors:  Q Zheng; K Olivier; Y K Won; C N Pope
Journal:  Toxicol Sci       Date:  2000-05       Impact factor: 4.849

7.  Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine.

Authors:  R Kuczenski; D S Segal
Journal:  J Pharmacol Exp Ther       Date:  2001-03       Impact factor: 4.030

Review 8.  Neuronal nicotinic receptors: from structure to pathology.

Authors:  C Gotti; F Clementi
Journal:  Prog Neurobiol       Date:  2004-12       Impact factor: 11.685

Review 9.  Acetylcholine systems and rhythmic activities during the waking--sleep cycle.

Authors:  Mircea Steriade
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

10.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

View more
  4 in total

1.  Fenproporex increases locomotor activity and alters energy metabolism, and mood stabilizers reverse these changes: a proposal for a new animal model of mania.

Authors:  Gislaine T Rezin; Camila B Furlanetto; Giselli Scaini; Samira S Valvassori; Cinara L Gonçalves; Gabriela K Ferreira; Isabela C Jeremias; Wilson R Resende; Mariane R Cardoso; Roger B Varela; João Quevedo; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2013-10-15       Impact factor: 5.590

2.  Effects of chronic administration of fenproporex on cognitive and non-cognitive behaviors.

Authors:  Cinara L Gonçalves; Camila B Furlanetto; Samira S Valvassori; Daniela V Bavaresco; Roger B Varela; Josiane Budni; João Quevedo; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2014-09-14       Impact factor: 3.584

3.  Effects of acute and chronic administration of fenproporex on DNA damage parameters in young and adult rats.

Authors:  Cinara L Gonçalves; Gislaine T Rezin; Gabriela K Ferreira; Isabela C Jeremias; Mariane R Cardoso; Samira S Valvassori; Bruna J P Munhoz; Gabriela D Borges; Bruno N Bristot; Daniela D Leffa; Vanessa M Andrade; João Quevedo; Emilio L Streck
Journal:  Mol Cell Biochem       Date:  2013-05-01       Impact factor: 3.396

4.  Characterization of the Antinociceptive Mechanisms of Khat Extract (Catha edulis) in Mice.

Authors:  Elham A Afify; Huda M Alkreathy; Ahmed S Ali; Hassan A Alfaifi; Lateef M Khan
Journal:  Front Neurol       Date:  2017-03-02       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.